Does Humana Cover Farxiga? Plans, Costs, and Restrictions

Humana does cover Farxiga (dapagliflozin) in 2026 across its Medicare Prescription Drug Plans, Medicare Advantage Part D plans, and Humana Healthy Horizons Medicaid managed care plans. On the Medicare formularies, both brand Farxiga and the generic sit on Tier 3 with a 30-tablet-per-30-day quantity limit and no prior authorization or step therapy. Medicaid coverage is tighter, with prior authorization and step therapy required.1PrescriberPoint. Farxiga Coverage – Humana

How Humana Medicare Plans Cover Farxiga

For the 2026 plan year, Humana’s Medicare Prescription Drug Plans and Medicare Advantage Part D plans place Farxiga and its generic equivalent, dapagliflozin propanediol, on Tier 3.2Humana. 2026 Commonly Prescribed Drug List – Humana Premier PDP Tier 3 in Humana’s system is the “Preferred Brand” level, which costs more than Tier 1 or Tier 2 generics but less than non-preferred or specialty tiers.3Humana. Understanding Drug Tiers

On the Humana Basic Rx Plan and the Humana Value Rx Plan, Farxiga carries a quantity limit of 30 tablets per 30 days, consistent with once-daily dosing.4Q1Medicare. Medicare Part D Drug Finder – Farxiga 5 MG Tablet Prior authorization and step therapy are not required on Humana’s Medicare plans,1PrescriberPoint. Farxiga Coverage – Humana so a prescription can be filled at the pharmacy without advance approval, as long as the quantity sits within the limit.

Jardiance (empagliflozin), the other common SGLT2 inhibitor, is also at Tier 3 on the same formularies.2Humana. 2026 Commonly Prescribed Drug List – Humana Premier PDP Humana treats them as equivalent options, so the choice usually comes down to the prescriber’s judgment and whatever difference shows up at the pharmacy counter.

How Humana Medicaid Plans Cover Farxiga

Humana Healthy Horizons, Humana’s Medicaid managed care line, also covers Farxiga, but with real restrictions. Available formulary data shows the Medicaid HMO plans require prior authorization, step therapy, and a quantity limit.1PrescriberPoint. Farxiga Coverage – Humana Step therapy means a member may need to try a preferred, lower-cost medication first. Prior authorization means the prescribing doctor has to submit clinical documentation before Humana will pay.

Humana Healthy Horizons operates in multiple states,5Humana Provider. Prior Authorization Lists and the clinical criteria for approval can differ from state to state. Medicaid members should check their state’s preferred drug list or call Humana member services for the specific rules that apply to them.

What You’ll Pay for Farxiga Under Humana

The actual copay or coinsurance depends on the plan, the pharmacy, and the Part D benefit phase the member is in: deductible, initial coverage, or catastrophic. AstraZeneca reports that the average out-of-pocket cost for Medicare Part D members was about $38.82 per month based on data through April 2023.6Farxiga. Savings and Support Current costs can look different for two reasons.

The Inflation Reduction Act capped Medicare Part D out-of-pocket spending at $2,000 a year starting in 2025. Once a member hits that ceiling, covered drugs cost nothing for the rest of the year. Many plans also allow members to spread that $2,000 in monthly installments instead of paying it in one hit during the deductible phase. The 2026 Part D deductible is $615.7UnitedHealthcare. Part D Changes Many plans have also moved from flat copays to coinsurance at Tier 3 and above, so what you pay can shift with the drug’s negotiated price at a given pharmacy.

The other change is generic competition. The FDA approved the first generic versions of dapagliflozin on April 7, 2026.8FDA. FDA Approves First Generic Dapagliflozin Tablets Generic entry usually brings cost-sharing down over time. On Humana’s 2026 commonly prescribed drug list, the brand and generic are both at Tier 3,2Humana. 2026 Commonly Prescribed Drug List – Humana Premier PDP but that placement may change as more generics enter the market and Humana updates its formularies.

If Your Plan Denies or Restricts Farxiga

When a Humana plan denies Farxiga or lists it on a tier that makes it unaffordable, members can request a formulary exception or a coverage determination. The most effective path is for the prescriber to contact Humana Clinical Pharmacy Review at 1-800-555-2546. Members can also submit requests themselves online, by fax to 877-486-2621, or by phone.9Humana. Prior Authorization Medication Approvals An exception can ask Humana to cover a non-formulary drug, waive prior authorization or step therapy, or move a drug to a lower cost-sharing tier.

If the request is denied, you have the right to appeal. The first level is a redetermination by Humana, filed within 65 calendar days of the denial notice. Humana must respond within seven calendar days for a standard request, or within 72 hours for an expedited appeal when waiting could seriously harm the patient’s health.10Humana Provider. Exceptions and Appeals If Humana upholds the denial, the case moves to an independent review entity, and Medicare Part D provides additional appeal levels beyond that.11Medicare.gov. Drug Plan Appeals Most disputes resolve well before reaching the higher levels.

Help Paying for Farxiga

AstraZeneca offers a Farxiga copay savings card, but it is limited to commercially insured patients. Anyone on a government-funded program like Medicare Part D or Medicaid is explicitly excluded,6Farxiga. Savings and Support which rules out Humana Medicare and Medicaid members. A few alternatives remain:

  • AZ&Me Prescription Savings Program. AstraZeneca’s patient assistance program provides medications at no cost to qualifying patients who are uninsured or on Medicare and cannot afford their prescriptions. Approved patients receive up to a 90-day supply shipped to their home or doctor’s office. Apply at azandmeapp.com or by phone at 1-800-292-6363.12AZ&Me. AZ&Me Prescription Savings Program
  • Independent charitable foundations such as The Assistance Fund, HealthWell Foundation, and the Patient Access Network Foundation sometimes offer copay assistance for specific conditions, though funding varies.13AstraZeneca. Affordability
  • Switching to generic dapagliflozin, if and when Humana lists it on a lower-cost tier than the brand.

What Humana Will Cover Farxiga For

Farxiga is an SGLT2 inhibitor. The FDA has approved dapagliflozin for four uses: type 2 diabetes in adults and children aged 10 and older; heart failure, regardless of whether the patient has diabetes; reducing heart failure hospitalizations in adults with type 2 diabetes and established cardiovascular disease or multiple risk factors; and chronic kidney disease at risk of progression.14FDA. Farxiga Prescribing Information15AstraZeneca. Farxiga Approved for Pediatric Type 2 Diabetes It is not approved for type 1 diabetes, is not recommended for blood sugar control once kidney function drops below a certain threshold, and is not recommended for CKD caused by polycystic kidney disease or in patients who recently received immunosuppressive therapy for kidney disease.

Humana’s Medicare coverage generally extends across all FDA-approved indications. Under Medicaid, the prior authorization and step therapy criteria may narrow the conditions for which Humana will actually approve the drug, which is why the specific state preferred drug list matters.